Literature DB >> 15511251

Persistence of septal defects after transeptal puncture for pulmonary vein isolation procedures.

Owen Obel1, Moussa Mansour, Michael Picard, Jeremy Ruskin, David Keane.   

Abstract

Pulmonary vein isolation (PVI) is widely practiced as a means of potentially curing atrial fibrillation (AF). Transeptal puncture is performed for PVI procedures, often two such punctures are performed. We sought to examine the prevalence of medium- to long- term iatrogenic septal defects after such procedures. Thirty-one patients who were undergoing their second PVI procedure were studied with transesophageal echocardiography (TEE) with two-dimensional imaging and color Doppler, examining the fossa ovalis for defects. Mean time from the original PVI to the time of TEE was 35 weeks. Two patients were discovered to have iatrogenic septal defects. The interval between the first PVI procedure and the TEE showing a septal defect was 33.7 weeks in one patient and 14.3 weeks in the other. Iatrogenic septal defects may occur in the medium- to long-term in patients undergoing PVI procedures for AF. The clinical implications of such defects are unknown.

Entities:  

Mesh:

Year:  2004        PMID: 15511251     DOI: 10.1111/j.1540-8159.2004.00646.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  8 in total

1.  High rate of persistent iatrogenic atrial septal defect after single transseptal puncture for cryoballoon pulmonary vein isolation.

Authors:  Markus Linhart; Jessica T Werner; Florian Stöckigt; Annika T Kohlmann; Pia C Lodde; Lutz P T Linneborn; Thomas Beiert; Christoph Hammerstingl; Roger Borràs; Georg Nickenig; René P Andrié; Jan W Schrickel
Journal:  J Interv Card Electrophysiol       Date:  2018-03-24       Impact factor: 1.900

2.  Prospective evaluation of iatrogenic atrial septal defect after cryoballoon or radiofrequency catheter ablation of atrial fibrillation-"EVITA" study.

Authors:  Zsofia Nagy; Zsuzsanna Kis; Tamás Géczy; Andras Temesvari; Zoltan Som; Sarolta Borbas; Tamás Breuer; David Molnar; Csaba Foldesi; Attila Kardos
Journal:  J Interv Card Electrophysiol       Date:  2019-08-09       Impact factor: 1.900

3.  Safety of atrial fibrillation ablation with novel multi-electrode array catheters on uninterrupted anticoagulation-a single-center experience.

Authors:  Christopher Ruslan Hayes; David Keane
Journal:  J Interv Card Electrophysiol       Date:  2010-03       Impact factor: 1.900

4.  A streamlined technique of trans-septal endocardial left ventricular lead placement.

Authors:  Ernest W Lau
Journal:  J Interv Card Electrophysiol       Date:  2009-04-22       Impact factor: 1.900

5.  Persistent iatrogenic atrial septal defects after pulmonary vein isolation: long-term follow-up with contrast transesophageal echocardiography.

Authors:  Allan Davies; Prasad Gunaruwan; Nicholas Collins; Malcolm Barlow; Nick Jackson; James Leitch
Journal:  J Interv Card Electrophysiol       Date:  2016-09-28       Impact factor: 1.900

6.  Persistent iatrogenic atrial septal defect after pulmonary vein isolation : incidence and clinical implications.

Authors:  Andreas Rillig; Udo Meyerfeldt; Ralf Birkemeyer; Fabian Treusch; Markus Kunze; Werner Jung
Journal:  J Interv Card Electrophysiol       Date:  2008-05-07       Impact factor: 1.900

7.  Thromboembolic Events Following Atrial Fibrillation Cardioversion and Ablation: What's the Culprit?

Authors:  Francesco De Sensi; Gennaro Miracapillo; Luigi Addonisio; Marco Breschi; Alberto Cresti; Pasquale Baratta; Francesco Paneni; Ugo Limbruno
Journal:  Medicina (Kaunas)       Date:  2019-08-20       Impact factor: 2.430

8.  Effectiveness and safety of single transseptal ablation for atrial fibrillation in real-word practice.

Authors:  Yoon Jung Park; Hee Tae Yu; Tae-Hoon Kim; Jae-Sun Uhm; Boyoung Joung; Moon-Hyoung Lee; Hui-Nam Pak
Journal:  Clin Cardiol       Date:  2021-02-22       Impact factor: 2.882

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.